Skip to product information
1 of 1

BT Lab

SKU:E1421Mo

Mouse F-box only protein 32,FBXO32/MAFbx ELISA Kit

Mouse F-box only protein 32,FBXO32/MAFbx ELISA Kit

Regular price $428.00 USD
Regular price Sale price $428.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Standard Range
Sensitivity

Contact us for 48 wells and bulk quote

The MOUSE F-BOX ONLY PROTEIN 32, FBXO32/MAFBX ELISA KIT is a highly advanced and sophisticated product designed to cater to the needs of researchers and scientists in the field of molecular biology. This kit is specifically designed to detect and quantify the levels of F-box only protein 32 (FBXO32) and muscle atrophy F-box (MAFBX) in mouse samples. The kit is based on the enzyme-linked immunosorbent assay (ELISA) technique, which is a highly sensitive and specific method for detecting and quantifying proteins in biological samples.

The MOUSE F-BOX ONLY PROTEIN 32, FBXO32/MAFBX ELISA KIT is manufactured using the highest quality materials and state-of-the-art technology to ensure accuracy, precision, and reproducibility of results. The kit includes all the necessary components required for the assay, including pre-coated plates, standards, detection antibodies, and buffers. The assay is easy to perform and can be completed within a short period of time.

The MOUSE F-BOX ONLY PROTEIN 32, FBXO32/MAFBX ELISA KIT is an essential tool for researchers and scientists studying the molecular mechanisms of muscle atrophy and related disorders. The kit provides accurate and reliable data on the levels of FBXO32 and MAFBX in mouse samples, which can be used to understand the underlying mechanisms of muscle wasting and develop new therapeutic strategies for the treatment of muscle atrophy.

In summary, the MOUSE F-BOX ONLY PROTEIN 32, FBXO32/MAFBX ELISA KIT is a highly advanced and reliable product that provides accurate and precise data on the levels of FBXO32 and MAFBX in mouse samples. The kit is easy to use, and its results can be used to advance research in the field of molecular biology and develop new therapeutic strategies for the treatment of muscle atrophy.

View full details